Stockreport

Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026

Beyond Air, Inc.  (XAIR) 
PDF Updated AACR poster data show continued survival follow-up in heavily pre-treated patients following a single intratumoral UNO injection Received US patent allowance c [Read more]